SGI
TMCI icon

Summit Global Investments’s Treace Medical Concepts TMCI Stock Holding History

Summit Global Investments’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,600
Closed -$285K – 612
2021
Q3 		$285K Buy
+10,600
New +$292K 0.02% 398

Other funds holding TMCI

CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Summit Global Investments's TMCI Position: Q4 2021 in Review

Summit Global Investments sold out of Treace Medical Concepts (TMCI) in Q4 2021, closing a stake of 10,600 shares — an estimated $285K sold.

Summit Global Investments first reported a position in TMCI in Q3 2021 and held it in 1 quarter. The position peaked at $285K in Q3 2021. 77 funds tracked by Wall St. Rank hold TMCI as of Q4 2021.

  • Summit Global Investments reported no remaining Treace Medical Concepts position as of Q4 2021 after selling out during the quarter.
  • Summit Global Investments sold 10,600 Treace Medical Concepts shares in Q4 2021, an estimated $285K.
  • Summit Global Investments first reported a position in Treace Medical Concepts in Q3 2021 and held it in 1 quarter.
  • Summit Global Investments's Treace Medical Concepts position peaked at $285K in Q3 2021.
  • 77 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2021.

Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.